Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3OXC

Wild Type HIV-1 Protease with Antiviral Drug Saquinavir

2NMW」から置き換えられました
3OXC の概要
エントリーDOI10.2210/pdb3oxc/pdb
関連するPDBエントリー2IEN 2NMY 2NMZ 2NNK 2NNP 3CYX 3D1X 3D1Y 3MWS 3NU3
関連するBIRD辞書のPRD_IDPRD_000454
分子名称Protease, (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide, FORMIC ACID, ... (5 entities in total)
機能のキーワードenzyme inhibition, aspartic protease, hiv/aids, saquinavir, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Human immunodeficiency virus 1
タンパク質・核酸の鎖数2
化学式量合計22436.37
構造登録者
Kovalevsky, A.Y.,Wang, Y.-F.,Tie, Y.,Weber, I.T. (登録日: 2010-09-21, 公開日: 2010-11-10, 最終更新日: 2023-09-06)
主引用文献Kovalevsky, A.Y.,Wang, Y.-F.,Tie, Y.,Weber, I.T.
Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir
Proteins, 67:232-242, 2007
Cited by
PubMed Abstract: Saquinavir (SQV), the first antiviral HIV-1 protease (PR) inhibitor approved for AIDS therapy, has been studied in complexes with PR and the variants PR(I) (84V) and PR(V) (82A) containing the single mutations I84V and V82A that provide resistance to all the clinical inhibitors. Atomic resolution crystal structures (0.97-1.25 A) of the SQV complexes were analyzed in comparison to the protease complexes with darunavir, a new drug that targets resistant HIV, in order to understand the molecular basis of drug resistance. PR(I) (84V) and PR(V) (82A) complexes were obtained in both the space groups P2(1)2(1)2 and P2(1)2(1)2(1), which provided experimental limits for the conformational flexibility. The SQV interactions with PR were very similar in the mutant complexes, consistent with the similar inhibition constants. The mutation from bigger to smaller amino acids allows more space to accommodate the large group at P1' of SQV, unlike the reduced interactions observed in darunavir complexes. The residues 79-82 have adjusted to accommodate the large hydrophobic groups of SQV, suggesting that these residues are intrinsically flexible and their conformation depends more on the nature of the inhibitor than on the mutations in this region. This analysis will assist with development of more effective antiviral inhibitors.
PubMed: 17243183
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.16 Å)
構造検証レポート
Validation report summary of 3oxc
検証レポート(詳細版)ダウンロードをダウンロード

237992

件を2025-06-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon